Thursday, September 15, 2016

BRIEF-Blirt sees negative results in pre-clinical study of its BS-154

* Says pre-clinical study of its BS-154 shows no competitive

advantage and limited commercial implementation possibility for

cancer treatment

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)